NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Cro S, Cornelius V, Capon F, et al. The interleukin 1 receptor antagonist anakinra to reduce disease severity of palmoplantar pustulosis in adults: APRICOT RCT and PLUM mechanistic study. Southampton (UK): NIHR Journals Library; 2022 Mar. (Efficacy and Mechanism Evaluation, No. 9.2.)
The interleukin 1 receptor antagonist anakinra to reduce disease severity of palmoplantar pustulosis in adults: APRICOT RCT and PLUM mechanistic study.
Show details- Study photography - The interleukin 1 receptor antagonist anakinra to reduce dis...Study photography - The interleukin 1 receptor antagonist anakinra to reduce disease severity of palmoplantar pustulosis in adults: APRICOT RCT and PLUM mechanistic study
Your browsing activity is empty.
Activity recording is turned off.
See more...